The results showed that the tumor weight and size were significantly decreased after treatment with PRTC for 4 weeks in comparison with those in the control mice, although the difference was slightly weaker than that in the CREPT deletion group (Figure 7F-G and Figure S4G). This evidence concerns the gene RPRD1B and neoplasm.